RecallDepth
Class III Terminated

Maxzide-25 (Triamterene and hydrochlorothiazide) tablets, USP, 37.5 mg/ 25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-0464-01

Company
Mylan Pharmaceuticals Inc.
Recall Initiated
June 7, 2018
Posted
June 20, 2018
Recall Number
D-0877-2018
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,620 bottles
Firm Location
Morgantown, WV, United States

Reason for Recall

Superpotent Drug: Composite assay results obtained during routine stability testing were slightly above specification.

Distribution

Product was distributed throughout the United States

Lot / Code Info

Lot #: 3087136, Exp 5/20

More recalls by Mylan Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class III Drug recalls